protege logo

Instance: Adrenergic_beta-antagonists

Types
Own Slots
  Slot Name Value
Alternatives  
CanImprove  
CautionWithMedicationsUsed  
Comment  
Contraindication  
CouldBeRelatedTo Heart_failure_NYHA_class_II, Acute_myocardial_infarction, Severe_heart_failure, Myocardial_ischemia, Heart_failure_NYHA_class_IV, Arrhythmia, Reduced_left_ventricular_ejection_fraction, Atrial_fibrillation, Heart_failure_NYHA_class_III, Chronic_heart_failure
Cui C0001645
Definition Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
DespiteReceivingTreatment  
DoNotUseWithMedicationGroup  
EspeciallyEffectiveAgainst Reduced_left_ventricular_ejection_fraction
Improves Mortality, Hospitalization, Normal_physical_activity, Any_heart_failure_class, Sudden_death_incidence_decrease
Incrementsmgday  
InitiatingDose  
MaintenanceDose  
MaximumRecommendedDailyDose  
MeanDailyDose  
RelevantSignOrSymptom  
SideEffect Bradycardia, Myocardial_dysfunction, Low_blood_pressure_disorder, Worsening_heart_failure
Synonyms Beta-adrenoceptor
TargetDose  
TitrationPeriod 2-4 weeks
TreatmentStatus  
Treats  
UMLSSynonyms Beta-blockers
UsedTogetherWithMedication  
UsedWithMedicationGroup Loop_diuretics_and_metolazone, Cardiac_glycosides, ACE_inhibitors
UseWhenExistsIntoleranceOf  
UseWithTest  

  ^ back to top

Return to Class Hierarchy

Generated: 09/08/2009, 5:06:40 PM, Central European Summer Time

Protégé is a trademark of Stanford University, Copyright (c) 1998-2006 Stanford University.